医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Wipro Rated as a ‘High Performer’ in HfS Report on Population Health and Care Management

2015年06月10日 PM10:30
このエントリーをはてなブックマークに追加


 

BANGALORE, India & EAST BRUNSWICK, N.J. & LONDON

Wipro Ltd. (NYSE:WIT), a leading global information technology, consulting and business process services company, today announced that it has been rated as a ‘High Performer’ by leading global analyst firm HfS Research, in the Population Health and Care Management (PHM) Business Services for U.S. Healthcare Providers and Payers, April 2015 Blueprint report.

Healthcare is undergoing a transformational shift due to pay for performance revolution, empowering patients and adoption of new value based models of care. With the advent of these care models, providers, payers, and accountable care organizations (ACOs) are engaging in managing the health of the population across the care continuum to improve outcomes and patient engagement, and reduce cost of care.

“We are delighted to be recognized by HfS,” said Mohd Haque, Vice President & Global Head – Healthcare, Wipro Ltd. “To be successful in the post-reform era, our healthcare clients require population health management platforms and capabilities to deliver coordinated and integrated care. We have developed robust business process services capabilities in population health and care management and along with industry leading PHM platform partners, our vision is to promote an ‘as a service’ model delivering end-to-end population health management services including digital, analytics, technology and business process services. To be named as a High Performer by HfS is a recognition and validation of our PHM strategy and investments in building differentiated domain capabilities.”

“Healthcare organizations, facing considerable change and complexity, will find a willing and able partner in Wipro,” said Barbra McGann, Managing Director, HfS Research author of the recent HfS Population Health and Care Management Blueprint. “In this Blueprint we specifically looked at how service providers are innovating and proactively working with healthcare organizations to deliver more consumer-centric services, ultimately achieving better health outcomes and lower costs. We were impressed by how Wipro is investing in partnerships, resources, and tools to enable seamless ‘behind the scenes’ operations and build more reliable datasets and applications for timely and more effective connections with consumers and patients.”

About Wipro Ltd.

Wipro Ltd. (NYSE:WIT) is a leading Information Technology, Consulting and Business Process Services company that delivers solutions to enable its clients to do business better. Wipro delivers winning business outcomes through its deep industry experience and a 360 degree view of “Business through Technology” – helping clients create successful and adaptive businesses. A company recognized globally for its comprehensive portfolio of services, a practitioner’s approach to delivering innovation, and an organization wide commitment to sustainability, Wipro has a workforce of over 150,000, serving clients in 175+ cities across 6 continents. For more information, please visit www.wipro.com.

Forward-looking and Cautionary Statements

Certain statements in this release concerning our future growth prospects are forward-looking statements, which involve a number of risks, and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in our earnings, revenue and profits, our ability to generate and manage growth, intense competition in IT services, our ability to maintain our cost advantage, wage increases in India, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, restrictions on immigration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks, our ability to successfully complete and integrate potential acquisitions, liability for damages on our service contracts, the success of the companies in which we make strategic investments, withdrawal of fiscal governmental incentives, political instability, war, legal restrictions on raising capital or acquiring companies outside India, unauthorized use of our intellectual property, and general economic conditions affecting our business and industry. Additional risks that could affect our future operating results are more fully described in our filings with the United States Securities and Exchange Commission. These filings are available at www.sec.gov. We may, from time to time, make additional written and oral forward-looking statements, including statements contained in the company’s filings with the Securities and Exchange Commission and our reports to shareholders. We do not undertake to update any forward-looking statement that may be made from time to time by us or on our behalf.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150610005494/en/

CONTACT

Wipro Media Contacts:
Purnima Burman
purnima.burman@wipro.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • 三叶草生物制药完成6,280万元人民币A轮融资
  • Clover Biopharmaceuticals Completes RMB 62.8 Million Series A Financing
  • Corindus Announces First Commercial Installation of CorPath® GRX System Outside of U.S.
  • Walmart, JD.com, IBM and Tsinghua University Launch a Blockchain Food Safety Alliance in China
  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-402の第I相中間データを発表